research and development
Dr Geoffrey Nichol joins Ikaria
June 22, 2010Research and Development Ikaria, appointment, research and development
US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
MedImmune Ventures appoints Ron Laufer
June 18, 2010Research and Development AstraZeneca, MedImmune, appointment, research and development
Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
ABPI appoints former AZ innovation head
June 17, 2010Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing
UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …
Former FDA and MHRA regulators join Parexel Consulting
June 16, 2010Research and Development CRO, Parexel, appointment, research and development
Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …
R&D: a new world order
June 16, 2010Manufacturing and Production, Research and Development industry, job cuts, research, research and development
Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …
Novavax makes manufacturing promotions
June 16, 2010Manufacturing and Production, Research and Development Novavax, appointment, manufacturing and production, research and development
US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …
Pfizer appoints neuroscience research head
June 10, 2010Research and Development Pfizer, appointment, research and development
Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …
Dr Laurent Audoly joins Pieris
June 9, 2010Research and Development Pieris, appointment, research and development
French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …
Idis appoints Richard Greatorex
June 8, 2010Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing
Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
UCB’s Kola joins Astex board
June 5, 2010Research and Development Astex, UCB, appointment, research and development
Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …
Pfizer R&D head exits for AstraZeneca
May 27, 2010Research and Development AstraZeneca, Pfizer, appointment, research and development
One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …
Silence Therapeutics promotes Jorg Kaufmann
May 21, 2010Research and Development Silence Therapeutics, appointment, research and development, rnai
Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
UCB’s Roch Doliveux joins Innovative Medicines Initiative board
May 19, 2010Research and Development UCB, appointment, research and development
UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …
Steve Howson to lead Ferring UK
May 18, 2010Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing
Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …
Cedra appoints Anthony Busa
May 14, 2010Research and Development CRO, Cedra, appointment, research and development
Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting …
Latest content
Five Facts about cardiovascular disease
